Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells
- PMID: 7793072
- DOI: 10.1006/viro.1995.1332
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells
Abstract
The vaccinia virus/bacteriophage T7 hybrid transient expression system employs a recombinant vaccinia virus that encodes the T7 RNA polymerase gene, a plasmid vector with a gene of interest regulated by a T7 promoter, and any cell line suitable for infection and transfection. Although high expression in a majority of cells is achieved, the severe cytopathic effects of vaccinia virus and the safety precautions required for use of infectious agents are undesirable features of the system. Here, we report the construction of a highly attenuated and avian host-restricted vaccinia virus recombinant that encodes the T7 RNA polymerase gene (MVA/T7 pol) and demonstrate the use of the virus for transient expression in mammalian cells. MVA/T7 pol has reduced cytopathic effects compared to the previously used replication-competent vaccinia virus, while providing a high level of gene expression in multiple mammalian cell lines.
Similar articles
-
Transient and inducible expression of vaccinia/T7 recombinant viruses.Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041. Methods Mol Biol. 2004. PMID: 15114006 Review.
-
Recombinant expression of proteoglycans in mammalian cells. Utility and advantages of the vaccinia virus/T7 bacteriophage hybrid expression system.Methods Mol Biol. 2001;171:201-19. doi: 10.1385/1-59259-209-0:201. Methods Mol Biol. 2001. PMID: 11450231 No abstract available.
-
Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression: effect of T7 RNA polymerase levels and alpha-amanitin.Virology. 1998 Apr 10;243(2):331-9. doi: 10.1006/viro.1998.9070. Virology. 1998. PMID: 9568032
-
Poxviruses as expression vectors.Curr Opin Biotechnol. 1997 Oct;8(5):573-7. doi: 10.1016/s0958-1669(97)80031-6. Curr Opin Biotechnol. 1997. PMID: 9353230 Review.
-
A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy.Cancer Gene Ther. 1995 Dec;2(4):281-9. Cancer Gene Ther. 1995. PMID: 8548582
Cited by
-
Negative-Strand RNA Virus-Vectored Vaccines.Methods Mol Biol. 2024;2786:51-87. doi: 10.1007/978-1-0716-3770-8_3. Methods Mol Biol. 2024. PMID: 38814390 Review.
-
Structural basis for dimerization of a paramyxovirus polymerase complex.Nat Commun. 2024 Apr 11;15(1):3163. doi: 10.1038/s41467-024-47470-7. Nat Commun. 2024. PMID: 38605025 Free PMC article.
-
The production of recombinant platelet-derived growth factor D using the second generation modified vaccinia Ankara viral system.Protein Sci. 2022 Nov;31(11):e4468. doi: 10.1002/pro.4468. Protein Sci. 2022. PMID: 36214056 Free PMC article.
-
Interaction of Pestiviral E1 and E2 Sequences in Dimer Formation and Intracellular Retention.Int J Mol Sci. 2021 Jul 6;22(14):7285. doi: 10.3390/ijms22147285. Int J Mol Sci. 2021. PMID: 34298900 Free PMC article.
-
The Erns Carboxyterminus: Much More Than a Membrane Anchor.Viruses. 2021 Jun 23;13(7):1203. doi: 10.3390/v13071203. Viruses. 2021. PMID: 34201636 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials